Free Trial

ADMA Biologics (ADMA) Insider Trading & Ownership

ADMA Biologics logo
$21.37 +0.74 (+3.59%)
(As of 11/20/2024 ET)

ADMA Biologics (NASDAQ:ADMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$13.22 M
Get ADMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling ADMA Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADMA Insider Buying and Selling by Quarter

ADMA Biologics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2024Lawrence P GuiheenDirectorSell9,000$18.47$166,230.00  
8/30/2024Kaitlin M Kestenberg-MessinaCOOSell24,150$16.90$408,135.00  
8/29/2024Jerrold B GrossmanDirectorSell136,861$17.27$2,363,589.47  
8/26/2024Adam S GrossmanCEOSell236,889$17.69$4,190,566.41  
8/23/2024Young KwonDirectorSell60,000$18.26$1,095,600.00  
6/14/2024Adam S GrossmanCEOSell100,000$10.72$1,072,000.00  
3/18/2024Steve ElmsDirectorSell49,887$6.01$299,820.87  
3/15/2024Steve ElmsDirectorSell183,008$6.01$1,099,878.08  
3/13/2024Steve ElmsDirectorSell407,000$6.21$2,527,470.00  
(Data available from 1/1/2013 forward)

ADMA Insider Trading Activity - Frequently Asked Questions

The list of insiders at ADMA Biologics includes Adam S Grossman, Brian Lenz, Bryant Fong, Jerrold B Grossman, Kaitlin M Kestenberg-Messina, Lawrence P Guiheen, Steve Elms, and Young Kwon. Learn more on insiders at ADMA.

3.70% of ADMA Biologics stock is owned by insiders. Learn more on ADMA's insider holdings.

The following insiders have purchased ADMA shares in the last 24 months: Adam S Grossman ($42,851.38), Brian Lenz ($19,999.98), Jerrold B Grossman ($482,300.00), and Young Kwon ($97,500.00).

Insiders have purchased a total of 176,976 ADMA shares in the last 24 months for a total of $642,651.36 bought.

The following insiders have sold ADMA shares in the last 24 months: Adam S Grossman ($8,617,595.67), Brian Lenz ($973,258.80), Bryant Fong ($5,546,886.48), Jerrold B Grossman ($2,363,589.47), Kaitlin M Kestenberg-Messina ($408,135.00), Lawrence P Guiheen ($166,230.00), Steve Elms ($3,927,168.95), and Young Kwon ($1,095,600.00).

Insiders have sold a total of 3,612,146 ADMA Biologics shares in the last 24 months for a total of $23,098,464.37 sold.

ADMA Biologics Key Executives

  • Mr. Adam S. GrossmanMr. Adam S. Grossman (Age 47)
    Co-Founder, President, CEO & Director
    Compensation: $1.59M
    2 recent trades
  • Dr. Jerrold B. Grossman D.P.S. (Age 76)
    Ph.D., Co-Founder & Vice Chairman of the Board
    Compensation: $90k
  • Ms. Kaitlin Kestenberg (Age 37)
    COO & Senior VP of Compliance
  • Mr. Drew Pantello
    Vice President of Marketing & Corporate Development
  • Ms. Cindy Petersen
    Executive Director of Human Resources
  • Mr. Skyler Bloom
    Senior Director of Business Development & Corporate Strategy
  • Mr. Brad Tade
    Vice President of Financial Operations


This page (NASDAQ:ADMA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners